Keywords
Cognitive dysfunction
Dementia
Glucagon-like-peptide 1
Glucagon-like-peptide 1 receptor agonist
Insulin resistance
Type 2 diabetes
AbbreviationsAβOs
Amyloid beta soluble oligomers
ADAS-Cog
Alzheimer's Disease Assessment Scale–Cognitive Subscale
AGEs
Advanced glycation end products
BVRT
Benton Visual Retention Test
CDR-Sob
Clinical Dementia Rating Scale Sum of Boxes
CFQ score
Cognitive Failures Questionnaire score
CMRglc
Cerebral metabolic rate for glucose
CVLT-II
California Verbal Learning Test-Second Edition
D-KEFS
Delis-Kaplan Executive Functioning System
DMT2
Type 2 Diabetes mellitus
DPP4i
Dipeptidyl Peptidase 4 inhibitors
DSST
Digit Symbol Substitution Test
fMRI
Functional magnetic resonance imaging
GLP-1
Glucagon-like-peptide 1
GLP-1R
Glucagon-like peptide 1 receptor
GLP-1 RA
Glucagon-like peptide 1 receptor agonist
GSK3β
Glycogen synthase kinase-3β
IDE
Insulin-degrading enzyme
IGF-I
IGF-II, Insulin-like growth factor I and II
MCI
Mild cognitive impairment
MMSE
Mini-Mental State Examination
MoCA
Montreal Cognitive Assessment
MRI
Magnetic resonance imaging
RCFT
Rey Complex Figure Test
RCT
Randomized controlled trial
ROS
Reactive oxygen species
SGLT2i
Sodium-glucose cotransporter-2 inhibitor
T2DM
Type 2 diabetes mellitus
TNF-α
Tumor Necrosis Factor - alpha
TMTA
B, Trail Making Test-A, B
WASI
Wechsler Abbreviated Scale of Intelligence
WAIS-III
Wechsler Adult Intelligence Scale-3rd Edition
Comments (0)